Volition(VNRX) - 2025 Q1 - Quarterly Results

Financial Performance - VolitionRx Limited reported financial results for Q1 2025, with a total revenue of $2.5 million, representing a 25% increase compared to Q1 2024[6] Business Strategy - The company confirmed a conference call scheduled for May 16, 2025, to discuss these results and business updates[6] - VolitionRx is focusing on expanding its product offerings and enhancing its technology for better market penetration[6]